Ligand Pharmaceuticals
LGND
LGND
132 hedge funds and large institutions have $712M invested in Ligand Pharmaceuticals in 2013 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 33 increasing their positions, 49 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
41% less call options, than puts
Call options by funds: $3.07M | Put options by funds: $5.23M
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Holders
132
Holding in Top 10
2
Calls
$3.07M
Puts
$5.23M
Top Buyers
| 1 | +$25.6M | |
| 2 | +$19.2M | |
| 3 | +$15M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$10.9M |
| 5 |
William Blair & Company
Chicago,
Illinois
|
+$9.35M |
Top Sellers
| 1 | -$43.7M | |
| 2 | -$20.3M | |
| 3 | -$18.1M | |
| 4 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$16.1M |
| 5 |
SCA
SAC Capital Advisors
Stamford,
Connecticut
|
-$11.9M |